Fundraising Fox

Sonnet BioTherapeutics Holdings

Princeton, US · Delaware corporation

Biotech

Founders & leadership

PM
Pankaj MohanFounder
JK
John K. CiniExecutive
SD
Susan DexterinExecutive
RK
Richard KennyExecutive
JC
Jay CrossinExecutive
MP
Michael PruittChief Executive Officer
EL
Eric LedererChief Financial Officer

Board

AD
Albert DyrnessBoard director
NB
Nailesh BhattBoard director
DG
Donald GriffithBoard director
RR
Raghu RaoBoard director
LM
Lori McNeilBoard director

Reported raises · per SEC filings

Form D private placements

$18M disclosed across 7 rounds · 2015–2024

▶$3.9MraisedDec 2024 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John K. CiniExecutive Officer
  • Albert DyrnessDirector
  • Nailesh BhattDirector
  • Pankaj MohanExecutive Officer, Director
  • Donald GriffithDirector
  • Susan DexterExecutive Officer
  • Richard KennyExecutive Officer
  • Raghu RaoDirector
  • Jay CrossExecutive Officer
  • Lori McNeilDirector
Offering amount
$3.9M
Amount sold
$3.9M
Sales commissions
$378.7K
Placement agents
Chardan Capital Markets, LLC
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedJul 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pankaj MohanExecutive Officer, Director
  • John K. CiniExecutive Officer
  • Raghu RaoDirector
  • Nailesh BhattDirector
  • Susan DexterExecutive Officer
  • Donald GriffithDirector
  • Richard KennyExecutive Officer
  • Albert DyrnessDirector
  • Jay CrossExecutive Officer
Offering amount
$2.3M
Amount sold
$2.3M
Sales commissions
$226.3K
Placement agents
Chardan Capital Markets, LLC
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedAug 2022 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Albert DyrnessDirector
  • Raghu RaoDirector
  • Susan DexterExecutive Officer
  • John K. CiniExecutive Officer
  • Jay CrossExecutive Officer
  • Pankaj MohanExecutive Officer, Director
  • Donald GriffithDirector
  • Nailesh BhattDirector
  • Richard KennyExecutive Officer
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedMay 2018 · 13 investors · Restaurants
Rule 506(b)
Officers, directors & promoters on the filing
  • Russell J. PageDirector
  • Keith J. JohnsonDirector
  • Neil C. KieferDirector
  • Larry S. SpitcaufskyExecutive Officer
  • Mark RobersonExecutive Officer
  • David P. OsbornDirector
  • J. Eric WagonerDirector
  • Eric LedererExecutive Officer
  • Michael D. PruittExecutive Officer, Director, Promoter
Offering amount
$1.4M
Amount sold
$1.4M
Minimum investment
$10.5K
Sales commissions
$36.8K
Placement agents
Oak Ridge Financial Services Group
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedMay 2017 · 14 investors · Restaurants
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith J. JohnsonDirector
  • Eric LedererExecutive Officer
  • Russell PageDirector
  • Michael D. PruittExecutive Officer, Director
  • Mark RobersonExecutive Officer
  • Gregory E. KrautDirector
  • Rich AdamsExecutive Officer
  • Neil C. KieferDirector
Offering amount
$6M
Amount sold
$6M
Minimum investment
$50K
Sales commissions
$260.2K
Placement agents
T.R. Winston & Company LLC
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedMar 2015 · 1 investors · Restaurants
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael PruittExecutive Officer, Director
  • Michael CarrollDirector
  • Russell PageDirector
  • Keith JohnsonDirector
  • Paul MoskowitzDirector
  • Eric LedererExecutive Officer
Offering amount
$1M
Amount sold
$1M
Minimum investment
$25K
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJan 2015 · 12 investors · Restaurants
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul MoskowitzDirector
  • Michael PruittExecutive Officer, Director
  • Michael CarrollDirector
  • Keith JohnsonDirector
  • Eric LedererExecutive Officer
  • Russell PageDirector
Offering amount
$1.1M
Amount sold
$1.1M
Minimum investment
$25K
Sales commissions
$9K
Placement agents
Source Capital Group
First sale
Jan 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Hyperliquid Strategies posts $318 million net loss on $262 million unrealized HYPE losses | The Blocktheblock.co · Feb 2026Buy Sonnet BioTherapeutics Stock – SONN Stock Quote Today & Investment Insights - Public.compublic.com · Dec 2025Sonnet BioTherapeutics Stockholders Approve Business Combination with Hyperliquid Strategies Inc and Rorschach I LLC | Quiver Quantitativequiverquant.com · Dec 2025Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update - BioSpacebiospace.com · Dec 2024SONN: Sonnet BioTherapeutics Holdings Inc Latest Stock Price, Analysis, News and Trading Ideasstocktwits.com

Frequently asked questions

Who founded Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings was founded by Pankaj Mohan.
How much funding has Sonnet BioTherapeutics Holdings raised?
Sonnet BioTherapeutics Holdings has disclosed $18M raised across 7 rounds.
Where is Sonnet BioTherapeutics Holdings headquartered?
Sonnet BioTherapeutics Holdings is headquartered in Princeton, US.